Janus Henderson Group PLC Grows Stock Holdings in Maximus, Inc. (NYSE:MMS)

Janus Henderson Group PLC lifted its position in Maximus, Inc. (NYSE:MMS) by 2.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,254,536 shares of the health services provider’s stock after purchasing an additional 25,825 shares during the quarter. Janus Henderson Group PLC owned 2.06% of Maximus worth $105,255,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Bayesian Capital Management LP purchased a new stake in Maximus in the first quarter worth approximately $512,000. Paloma Partners Management Co purchased a new stake in shares of Maximus in the 1st quarter valued at $320,000. Mount Yale Investment Advisors LLC grew its holdings in shares of Maximus by 12.6% during the 1st quarter. Mount Yale Investment Advisors LLC now owns 3,818 shares of the health services provider’s stock valued at $320,000 after purchasing an additional 426 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in Maximus by 6.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 38,100 shares of the health services provider’s stock worth $3,197,000 after purchasing an additional 2,322 shares during the period. Finally, LRI Investments LLC bought a new stake in Maximus in the first quarter worth $93,000. 97.21% of the stock is currently owned by institutional investors.

Maximus Trading Up 0.1 %

NYSE MMS traded up $0.13 during trading on Wednesday, hitting $93.12. 35,329 shares of the company’s stock traded hands, compared to its average volume of 331,915. The stock has a fifty day moving average of $87.42 and a two-hundred day moving average of $84.32. Maximus, Inc. has a 12-month low of $72.39 and a 12-month high of $93.86. The firm has a market cap of $5.66 billion, a P/E ratio of 24.41 and a beta of 0.75. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.53 and a quick ratio of 1.53.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Wednesday, May 8th. The health services provider reported $1.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.26. Maximus had a return on equity of 18.02% and a net margin of 4.58%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period last year, the company earned $0.80 EPS. Maximus’s revenue for the quarter was up 11.7% compared to the same quarter last year. As a group, sell-side analysts expect that Maximus, Inc. will post 5.79 EPS for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Saturday, August 31st. Investors of record on Thursday, August 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.29%. Maximus’s dividend payout ratio is currently 31.50%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.